NEOGEN2026-04-012026-06-30NEOGEN2026-04-012026-06-30in-capmkt:OtherExpenses1MemberNEOGEN2026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1NEOGEN2026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1NEOGEN2026-04-012026-06-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares542665NEOGENNOTLISTEDINE136S01016NEOGEN CHEMICALS LIMITEDMain BoardEquity2026-04-012027-03-312026-07-242026-07-20INRCroresQuarterlyFirst quarterSingle segmentSpecialty Chemicals2026-07-2414:00:002026-07-2418:30:00Declaration of unmodified opinion2026-04-012026-06-30UnauditedConsolidated250290000038600000254150000018003000007400000-4700000002530000002081000008200000042990000023107000002308000000230800000603000001400000617000000169100000000200000017110000017000001728000000000273800000106.296.29006.296.29The above unaudited Consolidated financial results of the Company for the quarter ended June 30, 2026 have <br /> been prepared in accordance with the IND AS, as prescribed under section 133 of the Companies Act, 2013 <br /> read with the Companies (Indian Accounting Standards) Rules, 2015 as amended and the other accounting <br /> principles generally accepted in India and are in compliance with the disclosure requirement of Regulations 33 <br /> and Regulations 52 of the Securities and Exchange Board of India (Listing Obligations & Disclosure <br /> Requirements) Regulations, 2015 as amended and were audited by the Statutory Auditor and recommended <br /> by the Audit Committee in its meeting held on July 24, 2026, to the Board for approval and was approved by <br /> the Board of Directors at their meeting held on July 24, 2026.Consolidated financial results comprises the unaudited financial results of Neogen Chemicals Limited (“Holding <br /> Company”), Dhara Fine chem Industries (a joint venture where the Holding Company is holding 90% of the <br /> capital contribution), the wholly owned subsidiaries of the Company namely Neogen lonics Limited and <br /> Neogen Chemicals Japan Corporation Limited and the step down subsidiary of the Company Neogen Morita <br /> New Materials Limited which was incorporated on July 30, 2025, together known as the “Group”.On March 05, 2025, there was fire at Multi-Purpose Plant (MPP3) Facility, Tank Farms and warehouse at Dahej <br /> SEZ Plant of the Group. This incident led to damage of certain property, plant and equipment, inventory and <br /> interrupted business. The Group is adequately insured for reinstatement value of damaged fixed assets, <br /> inventory and loss of profits due to business interruption. The Group has intimated the fire incident with the <br /> insurance company and submitted loss estimate pertaining to replacement value of the damaged property, <br /> plant and equipment, loss of damaged inventory and incidental expenses incurred on account of fire. The Claim <br /> is admitted by the insurance company.During the financial year ended March 31, 2025, the Group has recognised loss of Rs. 362.90 Crore on account <br /> of damage to certain property, plant & equipment, inventory and estimated cost of incidental charges. The <br /> Group has recognised insurance claim receivable of Rs. 348.82 Crore to the extent of recovery of loss after <br /> adjusting applicable deductibility considering its assessment of loss and admissibility of claims as per the policy, <br /> adequacy of coverage and nature of loss and based upon the independent opinion obtained by the Group from <br /> Independent Surveyor and Independent Expert Practitioner. The Group has not accounted claim for loss of <br /> profit due to business interruption and excess value of reinstatement of assets over written down value as per <br /> accounting conservatism. The aforementioned losses and corresponding insurance claim has been presented on a net basis of Rs. 14.08 Crore under exceptional item and claim receivable in other current financial assets in <br /> these consolidated financial results for the financial year ended March 31, 2025. <br /> The Company has received Rs. 149.38 Crore (Rs.140.00 Crore as on account payment from insurance company and <br /> balance Rs. 9.38 Crore pertains to sale of scrap) and incurred further incidental charges of Rs. 1.41 Crore which is <br /> also claimed as per insurance policy upto June 30, 2026. <br /> Subsequent to the quarter ended 30 June 2026, the Company has received additional Rs. 15.00 Crore as fourth <br /> on account payment from Insurance company, accordingly net claim receivable as on date reduced to Rs. 185.85 <br /> Crore.The Board of Directors of the Company, at its meeting held on March 7, 2026, inter alia approved the issue and <br /> offer of 10,00,000 equity shares of face value of Rs. 10 each at a price of Rs. 1,610 per Equity Share including a <br /> premium of Rs. 1,600 per Equity Share, aggregating to Rs. 1,61,00,00,000 (Rupees One Hundred and Sixty One <br /> Crore only) on preferential basis for cash consideration. Subsequently, the shareholders of the Company at its <br /> Extra Ordinary General meeting (EGM) held on March 29, 2026, has approved issue, offer and allotment of the <br /> said 10,00,000 equity shares to Cadamba Solutions Private Limited, a Promoter Group member of the <br /> Company. The allotment of the said equity shares of the Company on a preferential basis was done on April <br /> 18, 2026. The Equity Shares were listed on BSE Limited and National Stock Exchange of India Limited. <br /> Further we hereby confirm that there have been no deviations in the use of proceeds of issue of equity shares <br /> on preferential basis from the objects stated in the Notice dated March 7, 2026 for EGM held on March 29,2026 <br /> read with corrigendum to the said notice of EGM dated March 17, 2026 , for the quarter ended June 30,2026 <br /> and the intimation in this regard is being made available at https://neogenchem.com/announcements/ under <br /> the tab issue of securities and at the website of BSE Limited at https://www.bseindia.com/stock-shareprice/ <br /> neogen-chemicals-ltd/neogen/542665 and of National Stock exchange of India Limited at <br /> https://www.nseindia.com/get-quote/equity/NEOGEN/Neogen-Chemicals-Limited .# The figures for the quarter ended March 31, 2026 is arrived at as difference between the audited figures in <br /> respect of the full financial year and the unaudited figures up to nine months period ended December 31, 2025 <br /> which were subjected to limited review. <br /> 9. Previous period / year's figures have been regrouped / rearranged wherever necessary to make them <br /> comparable with the current period's classification. <br /> 10. The Group is primarily engaged in the business of manufacturing and sale of Specialty chemicals and battery <br /> chemicals and considering that the nature of products and the predominant risk and returns of the products are <br /> similar, the Group considers it as single operating/ reportable segment in accordance with Ind AS 108.The above unaudited consolidated financial results under SEBI (Listing Obligations and Disclosure Requirements) <br /> Regulations, 2015 for the quarter ended June 30, 2026 are available at the Company's website at <br /> https://necgenchem.com/financial-performance/, https://neogenchem.com/annual-reports-2/ and Stock <br /> Exchange's website at www.nseindia.com and www.bseindia.com.Other Expenses429900000Items that will not be reclassified to profit or loss26000002600000600000Items that will be reclassified to profit or loss-300000-30000001700000UnauditedfalseM/s. Chandabhoy & Jassoobhoy, Chartered Accountantstrue2026-10-31